Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9


Clinical HIV-1 isolates remain sensitive to stavudine following prolonged therapy.

Deminie CA, Bechtold CM, Riccardi K, Rose RE, Samanta H, Lin PF, Colonno RJ.

AIDS. 1998 Jan 1;12(1):110-2. No abstract available.


Evaluation of reverse transcriptase and protease inhibitors in two-drug combinations against human immunodeficiency virus replication.

Deminie CA, Bechtold CM, Stock D, Alam M, Djang F, Balch AH, Chou TC, Prichard M, Colonno RJ, Lin PF.

Antimicrob Agents Chemother. 1996 Jun;40(6):1346-51.


Potentiation of the stavudine anti-human immunodeficiency virus activity by 5-fluorouracil.

Gong YF, Bechtold CM, Robinson BS, Lin PF.

Antimicrob Agents Chemother. 1996 May;40(5):1329. No abstract available.


Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.

Rose RE, Gong YF, Greytok JA, Bechtold CM, Terry BJ, Robinson BS, Alam M, Colonno RJ, Lin PF.

Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1648-53.


Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor.

Lin PF, Samanta H, Bechtold CM, Deminie CA, Patick AK, Alam M, Riccardi K, Rose RE, White RJ, Colonno RJ.

Antimicrob Agents Chemother. 1996 Jan;40(1):133-8.


Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor.

Patick AK, Rose R, Greytok J, Bechtold CM, Hermsmeier MA, Chen PT, Barrish JC, Zahler R, Colonno RJ, Lin PF.

J Virol. 1995 Apr;69(4):2148-52.


Antiviral properties of aminodiol inhibitors against human immunodeficiency virus and protease.

Bechtold CM, Patick AK, Alam M, Greytok J, Tino JA, Chen P, Gordon E, Ahmad S, Barrish JC, Zahler R, et al.

Antimicrob Agents Chemother. 1995 Feb;39(2):374-9.


Genotypic and phenotypic analysis of human immunodeficiency virus type 1 isolates from patients on prolonged stavudine therapy.

Lin PF, Samanta H, Rose RE, Patick AK, Trimble J, Bechtold CM, Revie DR, Khan NC, Federici ME, Li H, et al.

J Infect Dis. 1994 Nov;170(5):1157-64.


Substituted naphthalenones as a new structural class of HIV-1 reverse transcriptase inhibitors.

Alam M, Bechtold CM, Patick AK, Skoog MT, Gant TG, Colonno RJ, Meyers AI, Li H, Trimble J, Lin PF.

Antiviral Res. 1993 Oct;22(2-3):131-41.


Supplemental Content

Loading ...
Support Center